{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:08:56Z","timestamp":1775336936937,"version":"3.50.1"},"reference-count":83,"publisher":"American Geophysical Union (AGU)","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1021\/js980082d","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T09:40:54Z","timestamp":1030268454000},"page":"1322-1330","source":"Crossref","is-referenced-by-count":370,"title":["Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics\u2020"],"prefix":"10.1029","volume":"87","author":[{"given":"Vincent J.","family":"Wacher","sequence":"first","affiliation":[]},{"given":"Jeffrey A.","family":"Silverman","sequence":"additional","affiliation":[]},{"given":"Yuanchao","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Leslie Z.","family":"Benet","sequence":"additional","affiliation":[]}],"member":"13","reference":[{"key":"10.1021\/js980082d_bb0010","first-page":"414","article-title":"Interindividual variations in human liver cyto-chrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver mi-crosomes of 30 Japanese and 30 caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI113156","article-title":"Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man","volume":"80","author":"Watkins","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1021\/js980082d_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and cancer chemotherapy","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol. Carcinog."},{"key":"10.1021\/js980082d_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0169-409X(95)00127-S","article-title":"Active secretion and enterocytic drug metabolism barriers to drug absorption","volume":"20","author":"Wacher","year":"1996","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1021\/js980082d_bb0030","series-title":"Goodman and Gilman's The Pharmacologic Basis of Therapeutics","first-page":"3","article-title":"Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination","author":"Benet","year":"1996"},{"key":"10.1021\/js980082d_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/019262339602400107","article-title":"An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials","volume":"24","author":"Parkinson","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1021\/js980082d_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","article-title":"P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature","volume":"6","author":"Nelson","year":"1996","journal-title":"Pharmaco-genetics"},{"key":"10.1021\/js980082d_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/dna.1988.7.79","article-title":"Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase","volume":"7","author":"Gonzalez","year":"1988","journal-title":"DNA"},{"key":"10.1021\/js980082d_bb0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1432-1033.1993.tb18412.x","article-title":"Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control","volume":"218","author":"Hashimoto","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1021\/js980082d_bb0055","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1016\/S0021-9258(18)81632-5","volume":"264","author":"Aoyama","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1021\/js980082d_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0003-9861(89)90449-9","article-title":"Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver","volume":"274","author":"Schuetz","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1021\/js980082d_bb0065","first-page":"97","article-title":"Identification of a polymorphically expressed member of the human cytochrome P-450III family","volume":"36","author":"Wrighton","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1021\/js980082d_bb0070","first-page":"207","article-title":"Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol","volume":"38","author":"Wrighton","year":"1990","journal-title":"Pharmacol."},{"key":"10.1021\/js980082d_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0003-9861(85)90383-2","article-title":"Purification and properties of cytochrome P-450 from homogenates of human fetal livers","volume":"241","author":"Kitada","year":"1985","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1021\/js980082d_bb0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0003-9861(89)90575-4","article-title":"Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family","volume":"268","author":"Wrighton","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1021\/js980082d_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.jbchem.a122632","article-title":"Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450","volume":"105","author":"Komori","year":"1989","journal-title":"J. Biochem."},{"key":"10.1021\/js980082d_bb0090","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/bi00470a024","article-title":"Fetus-specific expression of a form of cytochrome P-450 in human livers","volume":"29","author":"Komori","year":"1990","journal-title":"Biochemistry"},{"key":"10.1021\/js980082d_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00008571-199402000-00002","article-title":"Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver","volume":"4","author":"Schuetz","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1021\/js980082d_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-2952(94)90223-2","article-title":"Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver","volume":"48","author":"Hakkola","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1021\/js980082d_bb0105","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1073\/pnas.82.18.6310","article-title":"Identification of an inducible form of cytochrome P-450 in human liver","volume":"82","author":"Watkins","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0110","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1073\/pnas.83.14.5311","article-title":"Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver","volume":"83","author":"Molowa","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0115","first-page":"787","article-title":"Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins","volume":"55","author":"Hashimoto","year":"1995","journal-title":"Cancer Res."},{"key":"10.1021\/js980082d_bb0120","first-page":"199","article-title":"Drug metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P450","volume":"2","author":"Cresteil","year":"1982","journal-title":"Pediatr. Pharmacol."},{"key":"10.1021\/js980082d_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0003-9861(91)90602-F","article-title":"Steroid hormone hydrox-ylase specificities of eleven cDNA-expressed cytochrome P450s","volume":"290","author":"Waxman","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1021\/js980082d_bb0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0006-2952(87)90350-9","article-title":"Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations","volume":"36","author":"Kitada","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1021\/js980082d_bb0135","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of mida-zolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1021\/js980082d_bb0140","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1021\/js980082d_bb0145","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/hep.1840180535","article-title":"Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes","volume":"18","author":"Schuetz","year":"1993","journal-title":"Hepatology"},{"key":"10.1021\/js980082d_bb0150","first-page":"415","article-title":"Comparative analysis of cytochrome P450 3A induction in primary cultures of rat, rabbit and human hepatocytes","volume":"23","author":"Kocarek","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js980082d_bb0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1006\/bbrc.1996.1231","article-title":"The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture","volume":"225","author":"Greuet","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1021\/js980082d_bb0160","first-page":"311","article-title":"Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately upregulate these proteins in human colon carcinomas","volume":"49","author":"Schuetz","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1021\/js980082d_bb0165","first-page":"549","article-title":"Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients","volume":"271","author":"Thummel","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0170","first-page":"557","article-title":"Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation","volume":"271","author":"Thummel","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008571-199410000-00003","article-title":"CYP3A gene expression in human gut epithelium","volume":"4","author":"Kolars","year":"1994","journal-title":"Pharma-cogenetics"},{"key":"10.1021\/js980082d_bb0180","first-page":"947","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js980082d_bb0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.36.2.259","article-title":"Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues","volume":"36","author":"McKinnon","year":"1995","journal-title":"Gut"},{"key":"10.1021\/js980082d_bb0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2125.1996.42615.x","article-title":"Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue","volume":"42","author":"Kivist\u00f6","year":"1996","journal-title":"Br. J. Clin. Phar-macol."},{"key":"10.1021\/js980082d_bb0195","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI119439","article-title":"Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression","volume":"99","author":"Lown","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1021\/js980082d_bb0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","article-title":"Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporin A","volume":"62","author":"Lown","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0205","first-page":"1552","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/mol.51.5.741","article-title":"Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1\u03b1,25-dihydroxyvitamin D3","volume":"51","author":"Schmiedlin-Ren","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1021\/js980082d_bb0215","first-page":"387","article-title":"Cytochrome P450 isoenzymes, epoxide hydro-lase and glutathione transferases in rat and human hepatic and extrahepatic tissues","volume":"253","author":"De Waziers","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0225","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"Thummel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000139380","article-title":"Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine","volume":"52","author":"Lampen","year":"1996","journal-title":"Pharmacology"},{"key":"10.1021\/js980082d_bb0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00008571-199610000-00001","article-title":"Selective expression of CYP3A5 and not CYP3A4 in human blood","volume":"6","author":"Janardan","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1021\/js980082d_bb0240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.1996.0618","article-title":"Detection of a CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein?","volume":"221","author":"Jouna\u00efdi","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1021\/js980082d_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-9861(92)90159-T","article-title":"Expression of cytochrome P450 3A in amphibian, rat and human kidney","volume":"294","author":"Schuetz","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1021\/js980082d_bb0250","first-page":"52","article-title":"Bimodal distribution of renal cytochrome P450 3A activity in humans","volume":"50","author":"Haehner","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1021\/js980082d_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-2952(92)90055-N","article-title":"Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA","volume":"44","author":"Wheeler","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1021\/js980082d_bb0260","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/ajrcmb.16.3.9070608","article-title":"Expression and localization of CYP3A4 and CYP3A5 in human lung","volume":"16","author":"Anttila","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1021\/js980082d_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(95)00367-I","article-title":"Cytochrome P450 CYP3A5 in the human anterior pituitary gland","volume":"364","author":"Murray","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1021\/js980082d_bb0270","first-page":"185","article-title":"Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical","volume":"26","author":"Lown","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js980082d_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","article-title":"The biochemistry of P-glycoprotein mediated multidrug resistance","volume":"58","author":"Endicott","year":"1989","journal-title":"Annu. Rev. Biochem."},{"key":"10.1021\/js980082d_bb0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0163-7258(93)90011-2","article-title":"Classical and novel forms of multidrug resistance and the physiological functions of P-glycoprotein in mammals","volume":"60","author":"Borst","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"10.1021\/js980082d_bb0290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2007-1007233","article-title":"Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein","volume":"16","author":"Muller","year":"1996","journal-title":"Semin. Liv. Disease"},{"key":"10.1021\/js980082d_bb0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0300","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2125.1988.tb03331.x","article-title":"The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450","volume":"25","author":"Murray","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1021\/js980082d_bb0310","first-page":"256","article-title":"Selective biotransforma-tion of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P450 3A4. Potential contribution to high first-pass metabolism","volume":"25","author":"Fitzsimmons","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js980082d_bb0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-2952(96)00693-4","article-title":"Colchicine biotransformation by human liver mi-crosomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation","volume":"53","author":"Tateishi","year":"1997","journal-title":"Biochem. Pharma-col."},{"key":"10.1021\/js980082d_bb0320","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.93.9.4001","article-title":"P-glycoprotein, a major determinant of rifampicin-inducible expression of cytochrome P450 3A in mice and humans","volume":"93","author":"Schuetz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0325","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0009-9236(95)90168-X","article-title":"Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine","volume":"58","author":"Wu","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0330","first-page":"15","article-title":"Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction","volume":"58","author":"Hebert","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0009-9236(95)90067-5","article-title":"The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine","volume":"58","author":"Gomez","year":"1995","journal-title":"Clin. Phar-macol. Ther."},{"key":"10.1021\/js980082d_bb0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0009-9236(95)90032-2","article-title":"Disposition of intravenous and oral cyclosporine after administration with grapefruit juice","volume":"57","author":"Ducharme","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0345","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0009-9236(96)80007-5","article-title":"The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers","volume":"59","author":"Chang","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1021\/js980082d_bb0350","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","article-title":"First-pass metabolism of cyclosporine by the gut","volume":"338","author":"Kolars","year":"1991","journal-title":"Lancet"},{"key":"10.1021\/js980082d_bb0355","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/j.1476-5381.1996.tb15612.x","article-title":"Relevance of P-glycoprotein for the enteral absorption of cyclosporin A, in vitro-in vivo correlation","volume":"118","author":"Fricker","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1021\/js980082d_bb0360","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexa-methasone, digoxin and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1021\/js980082d_bb0365","first-page":"268","article-title":"Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease","volume":"11","author":"Merry","year":"1997","journal-title":"AIDS"},{"key":"10.1021\/js980082d_bb0370","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/AAC.41.3.654","article-title":"Pharmacoki-netic enhancement of inhibitors of the human immunodefi-ciency virus protease by coadministration with ritonavir. Antimicrob","volume":"41","author":"Kempf","year":"1997","journal-title":"Agents Chemother."},{"key":"10.1021\/js980082d_bb0375","doi-asserted-by":"crossref","first-page":"F29","DOI":"10.1097\/00002030-199704000-00001","article-title":"Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients","volume":"11","author":"Merry","year":"1997","journal-title":"AIDS"},{"key":"10.1021\/js980082d_bb0380","first-page":"5","article-title":"Grapefruit juice and saquinavir","volume":"235","author":"James","year":"1995","journal-title":"Aids Treatment News"},{"key":"10.1021\/js980082d_bb0385","article-title":"Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein","author":"Kim","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1021\/js980082d_bb0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1021\/js980082d_bb0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Reexamination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1021\/js980082d_bb0400","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/bjc.1991.328","article-title":"Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein","volume":"64","author":"Hunter","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1021\/js980082d_bb0405","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/jm00017a002","article-title":"Vinyl sulfones as mechanism-based cysteine protease inhibitors","volume":"38","author":"Palmer","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1021\/js980082d_bb0410","first-page":"360","article-title":"Overlapping substrate specificity of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor","volume":"26","author":"Zhang","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1021\/js980082d_bb0415","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","article-title":"Limited oral bioavailability of taxol and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine","volume":"94","author":"Sparreboom","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1021\/js980082d_bb0420","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/bjc.1997.530","article-title":"Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833","volume":"76","author":"van Asperen","year":"1997","journal-title":"Br. J. Cancer"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915506746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915506746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:02:25Z","timestamp":1626872545000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915506746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["S0022354915506746"],"URL":"https:\/\/doi.org\/10.1021\/js980082d","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}